VPL Chemicals – A Symbio Group Company
Plot No:64, Sompura Industrial Area, Dobbespet,Nelamangala Taluk, Bangalore, Karnataka, India -562111
Trusted API Manufacturer with Global Reach
VPL Chemicals, a 100% Symbio-owned company, stands as a cornerstone of Symbio’s manufacturing ecosystem - combining scientific depth, regulatory excellence, and operational agility. Located near Bangalore, the ANVISA- and WHO-GMP–approved facility exemplifies Symbio’s commitment to world-class quality, sustainability, and continuous innovation. With Certificates of Suitability (CEPs/COPPs), VPL is aligned with stringent global standards and serves as a trusted manufacturing partner to leading pharmaceutical companies worldwide.
Expertise in APIs and Value-Added Pellets & Granules
At its core, VPL specializes in the manufacture of high-quality Active Pharmaceutical Ingredients (APIs) across a diverse therapeutic spectrum, backed by strong process chemistry and a deep focus on green and efficient manufacturing. Complementing its API capabilities, VPL also houses a dedicated facility for pre-formulated bulk products (pellets and granules). These ready-to-use formats, available for most of our pharmaceutical enzymes and select APIs, enable partners to directly compress tablets or fill capsules, saving valuable development time, formulation effort, and ultimately cost. The facility is equally equipped to take on customized development projects, providing tailored solutions that add strategic value to every collaboration.
Global Presence and Regulatory Excellence
VPL’s manufacturing excellence extends across major markets, with exports to Germany, Spain, Portugal, Brazil, Mexico, Australia, South Korea, Turkey, and Russia, among others. Its reputation for reliability, regulatory strength, and science-led execution has made VPL a preferred partner for both regulated and emerging markets. As part of Symbio’s broader vision, VPL continues to push the boundaries of API and pre-formulated bulk options - building chemistry that connects global healthcare needs with sustainable, high-quality solutions.
Half yearly Compliance Report
Download Report
Symbio – Vizag Manufacturing Facility
Plot No 22H, SY NO 34P AND 35P,APSEZ Atchutapuram, Lalam Konduru Village, Rambili Mandal, Atchutapuram APSEZ, Anakapalli, Andhra Pradesh, India - 531001
Flagship Facility for Advanced API and CDMO Manufacturing
Symbio’s flagship manufacturing facility in Visakhapatnam (Vizag) stands as the embodiment of our vision to create globally benchmarked, future-ready infrastructure. Purpose-built to meet the world’s most stringent regulatory standards, the site is already WHO-GMP certified and USFDA/EUGMP audits awaited, with design and operating systems aligned to the expectations of stringent regulated markets.
Designed for Scale, Built for Precision
Spanning six acres with a capacity scalable to over 600 KL, the Vizag facility combines flexibility with scientific rigor. Equipped with cleanroom environments, multiple reaction suites, and advanced containment systems, it can seamlessly handle both small-volume, high-value molecules and large-scale commercial APIs. The site integrates green chemistry, solvent recovery, and process optimization frameworks, reflecting Symbio’s commitment to sustainable and efficient manufacturing.
CDMO-Ready Platform for Global Partnerships
Beyond its API strength, Vizag is at the heart of Symbio’s expanding CDMO platform - offering specialized infrastructure for advanced intermediates, and complex chemistry projects. The facility supports custom synthesis, process development, scale-up, and technology transfer for both regulated and emerging markets, enabling partners to shorten development timelines and achieve commercial viability with confidence.
Commitment to Quality, Compliance, and Collaboration
At Vizag, quality is engineered into every process. A dedicated QA and regulatory team ensures end-to-end compliance, while advanced digital monitoring systems enable real-time control and traceability. Backed by a team of seasoned scientists and manufacturing experts, Symbio’s Vizag facility represents the intersection of science, scale, and partnership - a trusted global platform designed to bring chemistry to life, responsibly and at scale.
Symbio – Tumkur Facility
Plot No. 40 - 43, Satyamanagala Industrial Area Tumkur, Karnataka, India - 572104
Specialized Enzyme-Based API and Intermediate Manufacturing
Spread across five acres, the GMP-compliant Tumkur facility focuses on the production of enzyme-based APIs, and intermediates, and complex biocatalytic processes. Its infrastructure supports the commercial production of pharmaceutical enzymes.
